Century Report
Lilly Bets $2.75B on AI - TCR 03/30/26
The 20-Second Scan * Eli Lilly signed a $2.75 billion deal with Hong Kong-based Insilico Medicine to bring AI-discovered drugs to the global market, with 28 compounds developed using generative AI and nearly half already in clinical stages. * A construction robot completed 100 megawatts of solar installation at the AES